SCHEMBL6958451

SCHEMBL6958451

O=C(CCCc1c[nH]c2ccc(Cl)cc12)N1CCCC(Cc2ccccc2)C1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 1/20 0.55
TACR3 P29371 1/20 0.55
ALDH1A1 P00352 1/20 0.52
HTR1A P08908 1/20 0.51
SLC6A4 P31645 1/20 0.51
MC5R P33032 2/20 0.46
MC3R P41968 1/20 0.46
MC1R Q01726 1/20 0.46
SNCA P37840 6/20 0.45
HTR1D P28221 1/20 0.45
HTR1B P28222 1/20 0.45
KMT2A Q03164 2/20 0.45
BCHE P06276 1/20 0.44
ACHE P22303 1/20 0.44
MEN1 O00255 1/20 0.44
LMNA P02545 1/20 0.44
TP53 P04637 1/20 0.44
MAPT P10636 1/20 0.44
TDP1 Q9NUW8 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6954934 0.93 TACR3 (0.55) TACR1TACR3ALDH1A1HTR1ASLC6A4
SCHEMBL6957626 0.90 TACR1 (0.55) TACR1TACR3ALDH1A1HTR1ASLC6A4
SCHEMBL6960228 0.87 SLC6A4 (0.55) TACR1TACR3ALDH1A1HTR1ASLC6A4
SCHEMBL6953209 0.87 TACR1 (0.52) TACR1TACR3ALDH1A1HTR1ASLC6A4
SCHEMBL6959388 0.86 TACR1 (0.51) TACR1TACR3ALDH1A1HTR1ASLC6A4
SCHEMBL6954843 0.84 TACR3 (0.55) TACR1TACR3ALDH1A1HTR1ASLC6A4
SCHEMBL6952765 0.82 TACR1 (0.52) TACR1TACR3ALDH1A1HTR1ASLC6A4
SCHEMBL6959582 0.82 TACR1 (0.52) TACR1TACR3ALDH1A1HTR1ASLC6A4
SCHEMBL6951363 0.82 HTR1A (0.55) HTR1ASLC6A4HTR1DHTR1BKMT2A
SCHEMBL6954412 0.81 TACR3 (0.43) TACR1TACR3KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6333339-B1 CENTRAL SYSTEM DISORDERS, SCHIZOPHRENIA AND COGNITION ACTIVATORS MERCK PATENT GELLSCHAFT MIT BESCHRANKTER (DE) 2001-12-25 US claimed
EP-0993458-A1 3-BENZYLPIPERIDINE MERCK PATENT GmbH (DE) 2000-04-19 EP claimed
WO-1998057953-A1 3-BENZYLPIPERIDINE MERCK PATENT GMBH (DE) 1998-12-23 WO claimed
EP-0993458-B1 3-BENZYLPIPERIDINE MERCK PATENT GMBH (DE) 2003-04-09 EP disclosed
US-6333339-B1 CENTRAL SYSTEM DISORDERS, SCHIZOPHRENIA AND COGNITION ACTIVATORS MERCK PATENT GELLSCHAFT MIT BESCHRANKTER (DE) 2001-12-25 US disclosed
EP-0993458-A1 3-BENZYLPIPERIDINE MERCK PATENT GmbH (DE) 2000-04-19 EP disclosed
WO-1998057953-A1 3-BENZYLPIPERIDINE MERCK PATENT GMBH (DE) 1998-12-23 WO disclosed